Cargando…
RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial
INTRODUCTION: Primary biliary cirrhosis (PBC) is an autoimmune liver disease with approximately 50% of patients experiencing fatigue. This can be a particularly debilitating symptom, affecting quality of life and resulting in social isolation. Fatigue is highlighted by patients as a priority for res...
Autores principales: | Jopson, Laura, Newton, Julia L, Palmer, Jeremy, Floudas, Achilleas, Isaacs, John, Qian, Jessica, Wilkinson, Jennifer, Trenell, Mike, Blamire, Andrew, Howel, Denise, Jones, David E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550715/ https://www.ncbi.nlm.nih.gov/pubmed/26297361 http://dx.doi.org/10.1136/bmjopen-2015-007985 |
Ejemplares similares
-
Factors associated with severity and persistence of fatigue in patients with primary biliary cholangitis: study protocol of a prospective cohort study with a mixed-methods approach (SOMA.LIV)
por: Toussaint, Anne, et al.
Publicado: (2022) -
Hepatic autotaxin overexpression in infants with biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2018) -
The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study
por: Rees, James, et al.
Publicado: (2020) -
Retrospective observational study of temporal trends and outcomes of hepatitis B screening in patients receiving rituximab
por: Haider, Mahnur, et al.
Publicado: (2020) -
Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016)